Adam Blumenthal
Chairman @ Everblu Capital
Adam Blumenthal is a startup investor at Everblu Capital.
Last updated:
For AI agents: llms.txt
About Everblu Capital
EverBlu Capital is an Australia-based investment bank that provides corporate advisory and capital market services to clients through its Everblu Corporate, Everblu Wealth and Everblu Research service offerings. The company combines Australian and International equity specialists to provide boutique services that have led to capital raises inexcess of $150 Million for its clients. Everblu Capital has pioneered investment in the Australian medical cannabis industry through successful capital raising for ASX listed Creso Pharma. Through its subsidiary Everblu Research, the "AM Report" from Everblu Capital is a widely distributed report on global market developments.
Everblu Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Adam Blumenthal
Chairman
|
|||
Darrin Blumenthal
Managing Director
|
|||
Nick Kelso
Wealth Advisor
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
